JANINE BOIVIN: Open Payments
NPI 1023024379 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,147 in 62 payments from 21 companies in 2025. Trend: 2023 $682 · 2024 $4,824 · 2025 $3,147
Food & beverage: $1,673Speaker / faculty: $1,138Travel & lodging: $336
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $1,330 |
| Eli Lilly and Company | 6 | $498 |
| Boston Scientific Corporation | 4 | $236 |
| Sumitomo Pharma America, Inc. | 8 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $160 |
| ACCORD HEALTHCARE, INC. | 5 | $141 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| Janssen Biotech, Inc. | 4 | $71 |
| Calyxo, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
Products named: KISUNLA, Nubeqa, Axonics, Camcevi, ORGOVYX, GEMTESA, LYNPARZA, AMS 700.
Industry payments across IN — which companies pay providers there.
